Sun BioPharma, Inc. Provides Business Update and Reports Q2 2020 Financial Results

    NEXT STORY
    Myovant Sciences Announces Corporate Updates and Financial Results for First Quarter Fiscal Year 2020
    PREV STORY
    Arcturus Therapeutics Announces that it has Initiated Dosing of its COVID-19 STARR™ mRNA Vaccine Candidate, LUNAR-COV19 (ARCT-021) in a Phase 1/2 study
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    AZN: H1 2016 Results

    AstraZeneca PLC 28 July 2016 07:00 This announcement contains inside information. H1 2016 Results ...

    author_avatar
    NASDAQ Market News

    ERYTECH to Present Pharmacodynamic Data from Phase 2/3 Trial of Eryaspase in ALL at ASCO 2018

    LYON, France, June 04, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext:ERYP) (Nasdaq:ERYP), a clinical-stage ...

    author_avatar
    NASDAQ Market News

    Global Blood Culture Tests Market Worth Reach USD 3,989 Million By 2025: Zion Market Research

    author_avatar
    NASDAQ Market News